0000914190-18-000365.txt : 20180830 0000914190-18-000365.hdr.sgml : 20180830 20180830161737 ACCESSION NUMBER: 0000914190-18-000365 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180828 FILED AS OF DATE: 20180830 DATE AS OF CHANGE: 20180830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Points Jeffrey S. CENTRAL INDEX KEY: 0001731414 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 181047310 MAIL ADDRESS: STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC. STREET 2: 1225 OLD HIGHWAY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-08-28 0001180145 Cardiovascular Systems Inc CSII 0001731414 Points Jeffrey S. 1225 OLD HIGHWAY 8 NW ST. PAUL MN 55112 0 1 0 0 Chief Financial Officer Common Stock 2018-08-28 4 A 0 4742 0 A 27971 D Common Stock 2018-08-28 4 A 0 14225 0 A 42196 D Restrictions lapse as to 1,581 shares on each of 8/28/19 and 8/28/20 and as to 1,580 shares on 8/28/21. Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2019, 2020 and 2021 versus the Company's peer group. /s/ Amanda Lorentz as Attorney-in-Fact for Jeffrey S. Points pursuant to Power of Attorney previously filed. 2018-08-30